Therapeutic targeting of intracellular toll-like and interleukin-1 receptor signaling for inhibiting infection, inflammation, and cancer.Greg SnyderJournal of Acquired Immune Deficiency Syndromes（2017）引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
